Table 1.
Patient characteristics
| Variable | Median (IQR) |
|---|---|
| Age, years | 59 (46–67) |
| Sex, n (male/female) | 55/94 |
| Body mass index, kg/m2 | 27.7 (24.8–31) |
| Alanine aminotransferase, U/L | 64 (36.5–102) |
| γ-Glutamyl transpeptidase, U/L | 61 (35.5–110.5) |
| Creatinine, µmol/L | 58.3 (48.6–74.3) |
| Hemoglobin A1c, % | 6.3 (5.7–7.2) |
| Total cholesterol, mmol/L | 4.9 (4.2–5.6) |
| Triglyceride, mmol/L | 1.5 (1.1–2.0) |
| Muscle mass, kg | 23.4 (20–29.7) |
| Muscle mass/ht2, kg/m2 | 9.6 (8.6–10.6) |
| ASM, kg | 17.7 (14.4–22) |
| SMI, kg/m2 | 7.1 (6.2–7.9) |
| Muscle mass (upper extremity), kg | 4.7 (3.9–6.2) |
| Muscle mass (upper extremity)/ht2 kg/m2 | 1.9 (1.7–2.2) |
| Muscle mass of lower extremity, kg | 13.1 (10.4–15.8) |
| Muscle mass of lower extremity/ht2 kg/m2 | 5.2 (4.6–5.8) |
| Fat mass, kg | 24.5 (19.1–31.9) |
| BFMI, kg/m2 | 10.1 (7.5–12.5) |
| Visceral fat area, cm2 | 129.2 (111–155.1) |
| Waist-hip ratio | 0.96 (0.92–1.00) |
| SMI/BFMI | 0.71 (0.54–0.92) |
IQR, interquartile range; ht2, height squared; ASM, appendicular skeletal muscle mass; SMI, skeletal muscle index; BFMI, body fat mass index